- Home
- INBX vs RC Comparison
INBX vs RC Comparison
Compare INBX & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | RC |
|---|---|---|
| Founded | 2010 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.2M | 424.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | INBX | RC |
|---|---|---|
| Price | $79.02 | $2.19 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 5 |
| Target Price | N/A | ★ $4.35 |
| AVG Volume (30 Days) | 242.1K | ★ 5.9M |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,400,000.00 | N/A |
| Revenue This Year | $563.00 | N/A |
| Revenue Next Year | N/A | $32.94 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.81 | $2.09 |
| 52 Week High | $94.57 | $7.40 |
Technical Indicators
Market Signals| Indicator | INBX | RC |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 35.09 |
| Support Level | $76.22 | $2.15 |
| Resistance Level | $94.57 | $2.37 |
| Average True Range (ATR) | 6.98 | 0.12 |
| MACD | -1.37 | 0.01 |
| Stochastic Oscillator | 21.45 | 21.11 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.